Abstract:Two different mechanisms are considered to be the primary cause of aging. Cumulative DNA damage caused by reactive oxygen species (ROS), the by-products of oxidative phosphorylation, is one of these mechanisms (ROS concept). Constitutive stimulation of mitogen- and nutrient-sensing mTOR/S6 signaling is the second mechanism (TOR concept). The flow- and laser scanning- cytometric methods were developed to measure the level of the constitutive DNA damage/ROS- as well as of mTOR/S6- signaling in individual cells. Specifically, persistent activation of ATM and expression of γH2AX in untreated cells appears to report constitutive DNA damage induced by endogenous ROS. The level of phosphorylation of Ser235/236-ribosomal protein (RP), of Ser2448-mTOR and of Ser65-4EBP1, informs on constitutive signaling along the mTOR/S6 pathway. Potential gero-suppressive agents rapamycin, metformin, 2-deoxyglucose, berberine, resveratrol, vitamin D3 and aspirin, all decreased the level of constitutive DNA damage signaling as seen by the reduced expression of γH2AX in proliferating A549, TK6, WI-38 cells and in mitogenically stimulated human lymphocytes. They all also decreased the level of intracellular ROS and mitochondrial trans-membrane potential ΔΨm, the marker of mitochondrial energizing as well as reduced phosphorylation of mTOR, RP-S6 and 4EBP1. The most effective was rapamycin. Although the primary target of each on these agents may be different the data are consistent with the downstream mechanism in which the decline in mTOR/S6K signaling and translation rate is coupled with a decrease in oxidative phosphorylation, (revealed by ΔΨm) that leads to reduction of ROS and oxidative DNA damage. The decreased rate of translation induced by these agents may slow down cells hypertrophy and alleviate other features of cell aging/senescence. Reduction of oxidative DNA damage may lower predisposition to neoplastic transformation which otherwise may result from errors in repair of DNA sites coding for oncogenes or tumor suppressor genes. The data suggest that combined assessment of constitutive γH2AX expression, mitochondrial activity (ROS, ΔΨm) and mTOR signaling provides an adequate gamut of cell responses to evaluate effectiveness of gero-suppressive agents.

Intercellular Transfer of Mitochondria between Senescent Cells through Cytoskeleton-Supported Intercellular Bridges Requires mTOR and CDC42 Signalling

Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing

mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership

Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence

Mitochondria are required for pro‐ageing features of the senescent phenotype

The mTORC1-autophagy pathway is a target for senescent cell elimination

Uncoupling of mTORC1 from E2F activity maintains DNA damage and senescence

Disruption of nucleocytoplasmic trafficking as a cellular senescence driver

Mitochondrial fatty acid oxidation drives senescence

Cellular senescence links mitochondria-ER contacts and aging

Cellular senescence is associated with reorganization of the microtubule cytoskeleton

Mitochondria pleiotropism in stem cell senescence: Mechanisms and therapeutic approaches

Cellular senescence: all roads lead to mitochondria

Aging-dependent Mitochondrial Dysfunction Mediated by Ceramide Signaling Inhibits Antitumor T Cell Response

Mitochondrial peptides modulate mitochondrial function during cellular senescence

mTOR and Aging: An Old Fashioned Dress

mTORC2: A neglected player in aging regulation

Senescent Cell Depletion Through Targeting BCL-Family Proteins and Mitochondria

Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling

Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence.